한림대학교성심병원

장대영 교수

031-380-3704 fhdzang@hallym.or.kr
  • 진료과 혈액종양내과

전문진료분야

소화기암(위암, 대장암, 간담도췌장암 등), 혈액질환(백혈병, 골수이형성증 등)

전화 예약 1577-1801
교수님사진

(주간) 진료시간표 (2022-08-15 ~ 2022-08-20)

진료시간표
진료시간
오전 외래진료외래진료외래진료
오후 외래진료
교수님 사진

기본정보

학력

학력

한림대학교 의과대학 의학박사(MD, Ph.D)

Fred Hutchinson Cancer Research Center (FHCRC), Seattle, USA, Post-Doc

경력

경력

현) 대한항암요법연구회(KCSG) 회장, 이사회의장

현) 한림대학교성심병원 혈액·종양내과 교수

현) 한림대학교의료원 중앙임상의학연구소 소장

Weil Cornell Cancer Center, New York, USA, Visiting Professor

FHCRC, Research Associate, Seattle, USA

서울아산병원 종양혈액내과 임상강사

학회활동

학회활동

국가항암신약개발사업단 현)자문위원

국민건강보험공단 현)약제급여평가위원, 현)산정특례위원

건강보험심사평가원 현)암질환심의위원

식품의약품안전처 현)항암제전략자문위원, 현)중앙약사심의위원, 현)심속심의자문위원

과기부 생명공학연구원 현)바이오규제위원

대한위암학회 현)상임이사

대한종양내과학회 현)윤리위원장, 기획이사

대한암학회 건강보험정책위원장

대한혈액학회 교육수련이사, 사회봉사교육이사

수상이력

수상이력

미국혈액학회 우수논문상

한림대학교 학술상

논문

Ramucirumab plus paclitaxel as a second-line treatment in HER2-positive gastric cancer: subgroup analysis of a nationwide, real-world study in Korea (KCSG-ST19-16) (GASTRIC CANCER)

Incidence of FGFR2 Amplification and FGFR2 Fusion in Patients with Metastatic Cancer Using Clinical Sequencing (Journal of Oncology)

A phase II study of chemotherapy in combination with telomerase peptide vaccine (GV1001) as second-line treatment in patients with metastatic colorectal cancer (Journal of Cancer)

Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen (Journal of Cancer Research and Clinical Oncology)

Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group (Cancer Research and Treatment)

Clinical insights into hematologic malignancies and comparative analysis of molecular signatures of acute myeloid leukemia in different ethnicities using an artificial intelligence offering (Medicine (United States))

A Bayesian network meta-analysis on systemic therapy for previously treated gastric cancer (Critical Reviews in Oncology/Hematology)

Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3) (European Journal of Cancer)

Treatment and Outcomes of Metastatic Pancreatic Cancer in Elderly Patients (Chemotherapy)

PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer (Journal of clinical oncology : official journal of the American Society of Clinical Oncology)
위암 임상진료지침 (한국임상암학회)

위암표준진료권고안 (대한의학회)

환우와 가족을 위한 혈액 질환 소개서 (대한혈액학회)

혈액학 / Hematology ((주)범문에듀케이션)

RECTAL CANCER-a multidisciplinary approach to management (Intech)

혈액학 / hematology (E*public)